Cells in the immune system rely on regulated adhesion to support a variety of important functions. Among them are pathogen recognition, leukocyte emigration into inflamed tissues, and lymphocyte recirculation between the primary circulation and the lymphatics. In pathological inflammation, adhesion permits inappropriately activated tissues to recruit immune cells to the inflammatory focus. This proposal is directed at understanding the leukocyte molecules which participate in adhesion reactions underlying vascular emigration, and at elucidating the role that a new class of molecule plays in the intracellular regulation of adhesion, a process sometimes turned """"""""inside-out"""""""" signalling. The principal tools to be used are biochemical and genetic. The application relies on the use of transgenic and knockout models to establish the participation of candidate enzymes and proteins which are thought to mediate the initial phases of inflammatory adhesion. A detailed analysis of the mechanism whereby P-selectin recognizes its composite target structure will be carried out, and the participation of a candidate fucosyltansferase in the formation of neutrophil ligands for E- and P-selectin will be explored. Identification of the mechanism by which cytohesins activate leukocyte integrins and their roles in other integrin adhesion events will also be examined.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043031-10
Application #
6176511
Study Section
Special Emphasis Panel (ZRG2-SSS-4 (02))
Program Officer
Badman, David G
Project Start
1990-07-01
Project End
2001-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
10
Fiscal Year
2000
Total Cost
$278,663
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Sun, Yuhua; Gershengorn, Marvin C (2002) Correlation between basal signaling and internalization of thyrotropin-releasing hormone receptors: evidence for involvement of similar receptor conformations. Endocrinology 143:2886-92
Fukumura, D; Xavier, R; Sugiura, T et al. (1998) Tumor induction of VEGF promoter activity in stromal cells. Cell 94:715-25
Xavier, R; Brennan, T; Li, Q et al. (1998) Membrane compartmentation is required for efficient T cell activation. Immunity 8:723-32
Ting, A T; Pimentel-Muinos, F X; Seed, B (1996) RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis. EMBO J 15:6189-96
Kolanus, W; Nagel, W; Schiller, B et al. (1996) Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 86:233-42
Pouyani, T; Seed, B (1995) PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell 83:333-43
Stanger, B Z; Leder, P; Lee, T H et al. (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81:513-23
Aruffo, A; Kolanus, W; Walz, G et al. (1991) CD62/P-selectin recognition of myeloid and tumor cell sulfatides. Cell 67:35-44
Aruffo, A; Melnick, M B; Linsley, P S et al. (1991) The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J Exp Med 174:949-52
Walz, G; Aruffo, A; Kolanus, W et al. (1990) Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science 250:1132-5